Reshma Rangwala
EVP & Chief Medical Officer at Karyopharm Therapeutics · 4 reported transactions in 1 company · latest trade Mar 2, 2026
Their trades
Sold | Mar 2, 2026 | Mar 2, 2026 close $9.59 → Oct 29, 2026 close $0.88. S&P 500 +12.5% over the same days. | ||
Sold | Sep 15, 2025 | Sep 15, 2025 close $6.26 → Oct 29, 2026 close $0.88. S&P 500 +16.9% over the same days. |
$47.7K
Mar 2, 2026 close $9.59 → Oct 29, 2026 close $0.88. S&P 500 +12.5% over the same days.
$2.6K
Sep 15, 2025 close $6.26 → Oct 29, 2026 close $0.88. S&P 500 +16.9% over the same days.